Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) — Financial Flexibility Index
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has a Financial Flexibility Index of 0.17x as of September 2025. Free cash flow of CN¥116.82 Million (operating CF CN¥109.83 Million minus capex CN¥6.99 Million) represents 0% of total liabilities (CN¥676.78 Million). Also explore 600613 net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A across 28 annual periods. Check 600613 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (1998–2025)
Year-by-year free cash flow to debt coverage for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A. For the full company profile including market capitalisation, see Shanghai Shenqi Pharmaceutical Investmen (600613) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.21x | CN¥157.69 Million | CN¥124.47 Million | CN¥747.59 Million | ▼ -40.5% |
| 2024 | 0.35x | CN¥244.18 Million | CN¥207.79 Million | CN¥689.01 Million | ▲ +31.2% |
| 2023 | 0.27x | CN¥240.10 Million | CN¥215.59 Million | CN¥888.77 Million | ▼ -21.3% |
| 2022 | 0.34x | CN¥345.87 Million | CN¥319.23 Million | CN¥1.01 Billion | ▼ -3.9% |
| 2021 | 0.36x | CN¥270.23 Million | CN¥184.26 Million | CN¥756.45 Million | ▲ +40.8% |
| 2020 | 0.25x | CN¥195.40 Million | CN¥99.10 Million | CN¥770.28 Million | ▲ +10.6% |
| 2019 | 0.23x | CN¥205.24 Million | CN¥128.28 Million | CN¥894.60 Million | ▼ -53.2% |
| 2018 | 0.49x | CN¥258.77 Million | CN¥148.53 Million | CN¥527.74 Million | ▲ +57.7% |
| 2017 | 0.31x | CN¥175.83 Million | CN¥66.99 Million | CN¥565.34 Million | ▲ +306.3% |
| 2016 | 0.08x | CN¥43.44 Million | CN¥570.41K | CN¥567.56 Million | ▼ -69.4% |
| 2015 | 0.25x | CN¥96.30 Million | CN¥30.12 Million | CN¥384.98 Million | ▲ +23.5% |
| 2014 | 0.20x | CN¥51.75 Million | CN¥-8.62 Million | CN¥255.60 Million | ▼ -71.5% |
| 2013 | 0.71x | CN¥130.33 Million | CN¥74.75 Million | CN¥183.42 Million | ▲ +270.2% |
| 2012 | -0.42x | CN¥-10.15 Million | CN¥-11.18 Million | CN¥24.31 Million | ▼ -1014.9% |
| 2011 | -0.04x | CN¥-1.18 Million | CN¥-3.33 Million | CN¥31.57 Million | ▼ -103.2% |
| 2010 | 1.18x | CN¥33.61 Million | CN¥33.04 Million | CN¥28.48 Million | ▲ +731.8% |
| 2009 | 0.14x | CN¥8.60 Million | CN¥7.69 Million | CN¥60.61 Million | ▼ -70.6% |
| 2008 | 0.48x | CN¥25.62 Million | CN¥25.26 Million | CN¥53.04 Million | ▲ +157.6% |
| 2007 | 0.19x | CN¥16.91 Million | CN¥16.01 Million | CN¥90.23 Million | ▲ +503.9% |
| 2006 | -0.05x | CN¥-4.88 Million | CN¥-6.05 Million | CN¥105.19 Million | ▼ -114.1% |
| 2005 | 0.33x | CN¥36.22 Million | CN¥32.72 Million | CN¥109.67 Million | ▲ +443.1% |
| 2004 | 0.06x | CN¥11.25 Million | CN¥4.96 Million | CN¥184.98 Million | ▲ +65.4% |
| 2003 | 0.04x | CN¥5.15 Million | CN¥4.52 Million | CN¥139.96 Million | ▼ -72.6% |
| 2002 | 0.13x | CN¥19.26 Million | CN¥16.02 Million | CN¥143.38 Million | ▲ +217.9% |
| 2001 | -0.11x | CN¥-17.91 Million | CN¥-20.51 Million | CN¥157.14 Million | ▼ -149.9% |
| 2000 | 0.23x | CN¥38.61 Million | CN¥26.85 Million | CN¥168.97 Million | ▲ +4.0% |
| 1999 | 0.22x | CN¥32.83 Million | CN¥-3.28 Million | CN¥149.46 Million | ▲ +14.1% |
| 1998 | 0.19x | CN¥74.01 Million | CN¥72.67 Million | CN¥384.28 Million | — |